Ophthalmology

Top Medical News
20 hours ago
In eyes with age-related macular degeneration (AMD), intravitreal administration of the complement C5 inhibitor avacincaptad pegol appears to reduce the growth of geographic atrophy, according to the results of a phase II/III trial.
Yesterday
Dexamethasone intravitreal implants (DII) can help maintain visual acuity (VA) in patients with macular oedema (ME) due to retinal vein occlusion (RVO) but cannot seem to reverse VA loss, a recent study has found.
5 days ago
A comprehensive prediction model that applies a machine learning algorithm allowing selection of the most predictive risk factors automatically achieves high discrimination abilities in calculating progression to advanced age-related macular degeneration (AMD), as shown in two cohort studies.
Stephen Padilla, 16 Apr 2021
COVID-19 may be transmitted through tears, as shown in some patients with laboratory-proven moderate to severe disease, according to a study. Conjunctival swab is a satisfactory method of collecting tears for assessing the presence of SARS-CoV-2 by reverse transcription polymerase chain reaction (RT-PCR).
07 Apr 2021
Broad screening for glaucoma helps lower the incidence of poor vision and blindness by as much as 50 percent, a study suggests.
06 Apr 2021
Older patients with myopic choroidal neovascularization (mCNV) have poorer vision than their younger counterparts and are more likely to develop concomitant vitreoretinal interface abnormalities, a recent study has found.
31 Mar 2021
Blue-blocking lenses are not necessarily better than standard clear lenses for individuals experiencing eye strain due to computer use, with a recent study reporting no marked improvements in signs or symptoms of eye strain.
Special Reports
Dr. David Eichenbaum, Dr. Dilsher Dhoot, Prof. Peter Campochiaro, Dr. Timothy Y Y Lai, 04 Sep 2020

Intravitreal injection of antiangiogenic agents is the standard of care for neovascular age-related macular degeneration (nAMD), however, frequent injections represent a considerable treatment burden for patients. Results of the Ladder and Archway studies, presented at the 38th Annual Meeting of the American Society of Retina Specialists (ASRS 2020), showed that administration of ranibizumab through a port delivery system (PDS) considerably reduced treatment burden, while maintaining comparable efficacy and safety vs intravitreal injections. In an interview with MIMS Doctor, Dr Timothy Lai of Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, discusses how PDS may transform the management of nAMD.

Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.